Enoxaparin is available as injection in 100 mg/mL concentration. It is also available as Prefilled syringes, graduated prefilled syringe and multiple dose vials.

• For awarding the procurement of purchasing 1,000.000 Enoxaparin Sodium injections from M/s Slim Pharmaceuticals (Pvt.) Limited. (International bids were called under 02 procurements for supplying ...

Enoxaparin Sodium (Preservative Free) Prefilled Syringes had US brand and generic sales of approximately $530 million, according to IQVIA Health over a 12-month period ending March 2023. Techdow USA’s ...

Techdow USA is introducing 30 mg, 40 mg, 60 mg, 80 mg, 100 mg, 120 mg and 150 mg strengths of generic Enoxaparin Sodium (Preservative Free) Prefilled Syringes, which is the generic of Sanofi ...

The U.S. Food and Drug Administration (FDA) has approved Dutch biotech argenx’s (NASDAQ:ARGX) (OTCPK:ARGNF) autoimmune disease drug Vyvgart Hytrulo, developed with Halozyme Therapeutics (NASDAQ ...

Enoxaparin is available as injection in 100 mg/mL concentration. It is also available as Prefilled syringes, graduated prefilled syringe and multiple dose vials.

FDA approves Argenx's Vyvgart Hytrulo prefilled syringe for self-injection in gMG and CIDP, offering flexible dosing and expanding treatment options.

The oral solution in the prefilled ENFit syringe offers a safer alternative for adult subarachnoid haemorrhage patients.

VYVGART ® Hytrulo prefilled syringe for self-injection is approved as a 20-to-30-second subcutaneous injection administered by a patient, caregiver, or healthcare professional.

Halozyme Therapeutics, Inc. (NASDAQ: HALO) (Halozyme) today announced that argenx has received U.S. Food and Drug Administration (FDA) approval of VYVGART® Hytrulo prefilled syringe for self-injection ...

The approval of VYVGART ® Hytrulo prefilled syringe for self-injection is supported by data from studies evaluating its bioequivalence to VYVGART ® Hytrulo in a vial.